Zucapsaicin
Systematic (IUPAC) name | |
---|---|
(Z)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide | |
Clinical data | |
Trade names | Civanex |
Topical | |
Identifiers | |
25775-90-0 | |
M02AB02 | |
PubChem | CID 1548942 |
ChemSpider | 1265956 |
UNII | 15OX67P384 |
Synonyms | Civamide; (Z)-Capsaicin; cis-Capsaicin |
Chemical data | |
Formula | C18H27NO3 |
305.41188 g/mol | |
SMILES
| |
|
Zucapsaicin (Civanex) is a medication used to treat osteoarthritis of the knee and other neuropathic pain. It is applied three times daily for a maximum of three months. It reduces pain, and improves articular functions. It is the cis-isomer of capsaicin. Civamide, manufactured by Winston Pharmaceuticals, is produced in formulations for oral, nasal, and topical use (patch and cream).[1]
Zucapsaicin has been tested for treatment of a variety of conditions associated with ongoing nerve pain. This includes herpes simplex infections; cluster headaches and migraine; and knee osteoarthritis.[2]
References
- ↑ Winston Pharmaceuticals website http://www.winstonlabs.com/productdevelopment/civamide.asp
- ↑ Zucapsaicin information from the National Library of Medicine http://druginfo.nlm.nih.gov/drugportal
|